Dr. Songhai Chen, Assistant Professor of Pharmacology received a two-year funding (2/1/2013 - 1/31/2015) from the Holden Comprehensive Cancer Center Breast Cancer Pilot grant. This funding will support Dr. Chen to study the function of WDR26 as a novel regulation of the PI3K/AKT pathway in breast cancer progression.